Search Results 11-20 of 13440 for Relaxin-2
... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...
... 2 diabetes (T2D) inadequately controlled on 2-3 non-insulin glucose-lowering medications. Participation eligibility. Participant eligibility includes age ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...
Natural History of Afferent Baroreflex Failure in Adults. Neurology. 2021 Jul 13; 97(2):e136-e144. Epub 2021 May 04. View PubMed; Singer W, Schmeichel AM, ...
... 2*gn/ltt-i1cof6aer-a3m2ne-4- efbmnfwlxf/about-this-site/termsl69tdihsrlo-use-policyo8ad-2*gn/ltt-00wliT167e-.ul2tofeyfr_f::nn/i-f:0wliT16Tnfn.>5 ua1 ...
The goal of this study is to evaluate a new approach to immunotherapy in NHL by combining two antibodies, veltuzumab and epratuzumab. For treatment, epratuzumab ...
Confused by all the treatment choices for type 2 diabetes? Use this guide to better understand the medicines available to help control blood sugar.
Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...
Or get at least 75 minutes of vigorous aerobic activity a week. You also can get an equal mix of the two types. Aim to exercise most days of the week. But even ...
Phase I: To investigate maximum tolerated dose (MTD), safety and tolerability, pharmacokinetics, exploratory biomarker and efficacy of BI 836858 monotherapy in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.